Scarica l'app Stockscreener
92.59
0.64%
-0.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$93.19
Aprire:
$93.32
Volume 24 ore:
1.09M
Relative Volume:
0.48
Capitalizzazione di mercato:
$18.32B
Reddito:
$7.68B
Utile/perdita netta:
$903.80M
Rapporto P/E:
20.81
EPS:
4.45
Flusso di cassa netto:
$1.14B
1 W Prestazione:
-1.35%
1M Prestazione:
+1.50%
6M Prestazione:
-16.22%
1 anno Prestazione:
-16.21%
Intervallo 1D:
$92.59
$94.57
Intervallo di 1 settimana:
$92.59
$95.95
Portata 52W:
$89.24
$116.71
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.59 | 18.57B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
What analysts say about Zimmer Biomet Holdings Inc. stockExceptional stock performance - Autocar Professional
What drives Zimmer Biomet Holdings Inc. stock priceMassive stock growth - Autocar Professional
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA (NYSE:ZBH) - Seeking Alpha
Jim Cramer Expresses Bullishness on Zimmer’s Acquisition of Monogram Technologies - MSN
Zimmer Biomet Holdings Inc. Stock Analysis and ForecastPowerful growth strategies - PrintWeekIndia
Is Zimmer Biomet Holdings Inc. a good long term investmentOverwhelming profit margins - Autocar Professional
What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN
Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal - MSN
Jim Cramer Bullish on Zimmer Biomet's Acquisition of Monogram Technologies - AInvest
Zimmer Expands Robotics Portfolio Acquiring Monogram Technologies for $177 Million - MSN
Zimmer Biomet Holdings Surges to 444th in Market Rankings with $235 Million Trading Volume - AInvest
Zimmer Biomet’s SWOT analysis: stock faces challenges amid strategic acquisitions - Investing.com Australia
Zimmer Biomet Q2 Earnings Preview: Navigating Market ChallengesNews and Statistics - IndexBox
What You Need To Know Ahead Of Zimmer Biomet's Earnings Release - Barchart.com
17 Stocks on Jim Cramer’s Radar - Insider Monkey
Zimmer bets on autonomous surgery with Monogram purchase - Yahoo Finance
Zimmer Biomet wins price target raise at Roth - Cantech Letter
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
BTIG Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer upgraded to Buy at Roth Capital on Monogram deal (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - AI Insider
Wall Street's Top Analyst Calls: Upgrades and Downgrades for Zimmer Biomet, Southwest, DoorDash, and More - AInvest
What Makes Zimmer Biomet Holdings (ZBH) an Investment Opportunity? - Insider Monkey
Zimmer Biomet Merges with Monogram Technologies - The Globe and Mail
Zimmer Biomet to acquire Monogram for $177m - Yahoo Finance
Zimmer Biomet Acquires Monogram Technologies for $144M in Cash and Earnout - AInvest
Why Zimmer Biomet Holdings Inc. stock attracts strong analyst attentionFree Stock Market Entry & Exit Signals - beatles.ru
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Monogram Technologies Inc. (NASDAQ: MGRM) - GlobeNewswire Inc.
Zimmer Biomet Announces Definitive Agreement To Acquire Monogram - timesuniononline.com
Zimmer Biomet to acquire Monogram Technologies for $177M - The Robot Report
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
Zimmer Biomet to buy Monogram for $177M in cash - MSN
Zimmer Biomet Holdings, Inc. agreed to acquire Monogram Technologies Inc. for $144 million. - MarketScreener
Su Group Holdings Limited shares rise 9.62% intraday due to Zimmer Biomet's acquisition of Monogram Technologies. - AInvest
Zimmer Biomet to acquire Texas orthopedic robotics company - Inside INdiana Business
Zimmer Biomet in $168M buy of ortho robotics maker Monogram - BioWorld MedTech
Zimmer Biomet to Acquire Monogram Technologies for $177M to Offer First Fully Autonomous Surgical Robot - HIT Consultant
Zimmer Biomet Bets Big On Robotic Surgery With $177 Million Deal - Finimize
Zimmer Biomet to acquire robotics company Monogram Technologies - Modern Healthcare
Zimmer Biomet acquisition of Monogram Technologies to expand capacity in robotics devices - The Journal Gazette
Citi maintains Neutral rating on Zimmer Biomet stock amid Monogram acquisition - Investing.com
Zimmer Biomet Holdings (ZBH) Announces Merger Agreement with Mon - GuruFocus
Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech - Benzinga
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):